Endothelial nitric oxide synthase and fractalkine chemokine receptor polymorphisms on angiographically assessed coronary atherosclerosis

Clinica Chimica Acta

Volumn 362, Issue 1-2, 2005, Pages 138-146

  Rios, Domingos L S ^a   Callegari Jacques, Sídia M ^a   Hutz, Mara H ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

CAD; CX3CR1; DNA polymorphism; eNOS

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CX3CR1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FRACTALKINE CHEMOKINE RECEPTOR; ISOENZYME; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING; RISK ASSESSMENT; SYMPTOM;

CASE-CONTROL STUDIES; CORONARY ARTERIOSCLEROSIS; FEMALE; GENE FREQUENCY; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; RECEPTORS, CYTOKINE; RECEPTORS, HIV;

EID: 27744514065     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2005.06.012     Document Type: Article

References (45)

1. G.K. Hansson Mechanisms of disease: inflammation, atherosclerosis, and coronary artery disease New Engl J Med 352 2005 1685 1695
2. C. Napoli, and L.J. Ignarro Nitric oxide and atherosclerosis Nitric Oxide 5 2001 88 97
3. S. Moncada, and A. Higgs The L-arginine-nitric oxide pathway New Engl J Med 329 1993 2002 2012
4. M.W. Radomski, R.M.J. Palmer, and S. Moncada Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium Lancet 1 1987 1057 1058
5. P. Kubes, M. Suzuki, and D.N. Granger Nitric oxide: an endogenous modulator of leukocyte adhesion PNAS 88 1991 4651 4655
6. R. Sarkar, E.G. Meinberg, J.C. Stanley, D. Gordon, and R.C. Webb Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells Circ Res 78 1996 225 230
7. N. Hogg, B. Kalyanaraman, J. Joseph, A. Struck, and S. Parthasarathy Inhibition of low-density lipoprotein oxidation by nitric oxide: potential role in atherogenesis FEBS Lett 334 1993 170 174
8. B.S. Oemar, M.R. Tschudi, N. Godoy, V. Brovkovich, T. Malinski, and T.F. Lüscher Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis Circulation 97 1998 2494 2498
9. P.J. Kuhlencordt, R. Gyurko, F. Han, M. Scherrer-Crosbie, T.H. Aretz, and R. Hajjar Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice Circulation 104 2001 448 454
10. A.D. Hingorani, C.F. Liang, J. Fatibene, A. Lyon, S. Monteith, and A. Parsons A common variant of the endothelial nitric oxide synthase (Glu298Asp) is a major risk factor for coronary artery disease in the UK Circulation 100 1999 1515 1520
11. K. Hibi, T. Ishigami, K. Tamura, S. Mizushima, N. Nyui, and T. Fujita Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction Hypertension 32 1998 521 526
12. M.G. Colombo, M.G. Andreassi, U. Paradossi, N. Botto, S. Manfredi, and S. Masetti Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298Asp polymorphism) to the presence, extent, and severity of coronary artery disease Heart 87 2002 525 528
13. D.M. McNamara, R. Holubkov, L. Postava, R. Ramani, K. Janosko, and M. Mathier Effect of the ASP298 variant of endothelial nitric oxide synthase on survival for patients with congestive heart failure Circulaton 107 2003 1598 1602
14. A. Gardemann, J. Lohre, S. Cayci, N. Katz, H. Tillmanns, and W. Haberbosch The T allele of the missense Glu298Asp endothelial nitric oxide synthase gene polymorphism is associated with coronary heart disease in younger individuals with high atherosclerotic risk profile Atherosclerosis 160 2002 167 175
15. H. Cai, D.E.L. Wilcken, and X.L. Wang The Glu-298-Asp (894G-T) mutation at exon 7 of the endothelial nitric oxide synthase gene and coronary artery disease J Mol Med 77 1999 511 514
16. O. Poirier, C. Mao, C. Mallet, V. Nicaud, S.M. Herrmann, and A. Evans Polymorphisms of the endothelial nitric oxide synthase gene - no consistent association with myocardial infarction in the ECTIM study Eur J Clin Invest 29 1999 284 290
17. M. Via, A. Lopez-Alomar, N. Valveny, E. Gonzalez-Perez, M. Bao, and E. Esteban Lack of association between eNOS gene polymorphism and ischemic heart disease in the Spanish population Am J Med Genet 116A 2003 243 248
18. I. Schmoelzer, W. Renner, B. Paulweber, L. Malaimare, B. Iglseder, and P. Schmid Lack of association of the Glu298Asp polymorphism of endothelial nitric oxide synthase with manifest coronary artery disease, carotid atherosclerosis and reactivity in two Austrian populations Eur J Clin Invest 33 2003 191 198
19. M. Nakayama, H. Yasue, M. Yoshimura, Y. Shimasaki, K. Kugiyama, and H. Ogawa T-786→C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm Circulation 99 1999 2864 2870
20. M. Nakayama, H. Yasue, M. Yoshimura, Y. Shimasaki, H. Ogawa, and K. Kugiyama T-786C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with myocardial infarction, especially without coronary organic stenosis Am J Cardiol 86 2000 628 634
21. M. Yoshimura, H. Yasue, M. Nakayama, Y. Shimasaki, H. Ogawa, and K. Kugiyama Genetic risk factors for coronary artery spasm: significance of endothelial nitric oxide synthase gene T-786→C and missense Glu 298 Asp variants J Investig Med 48 2000 367 374
22. M.G. Colombo, U. Paradossi, M.G. Andreassi, N. Botto, S. Manfredi, and S. Masetti Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease Clin Chem 49 2003 389 395
23. G.P. Rossi, M. Cesari, M. Zanchetta, S. Colonna, G. Maiolino, and L. Pedon The T-786C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study J Am Coll Cardiol 41 2003 930 937
24. R. Álvarez, P. González, A. Batalla, J.R. Reguero, G. Iglesias-Cubero, and S. Hevia Association between the NOS3 (- 786 T/C) and the ACE (I/D) DNA genotypes and early coronary artery disease Nitric Oxide 5 2001 343 348
25. J.E. Tanus-Santos, M. Desai, and D.A. Flockhart Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants Pharmacogenetics 11 2001 719 725
26. J.F. Bazan, K.B. Bacon, G. Hardiman, W. Wang, K. Soo, and D. Rossi A new class of membrane-bound chemokine with a CX3C motif Nature 385 1997 640 644
27. S. Qin, J.B. Rottman, P. Myers, N. Kassam, M. Weinblatt, and M. Loetscher The chomokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions J Clin Invest 101 1998 746 754
28. S. Faure, L. Meyer, D. Costagliola, C. Vaneensberghe, E. Genin, and B. Autran Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1 Science 287 2000 2274 2277
29. D. Moatti, S. Faure, F. Fumeron, M.E.W. Amara, P. Seknadji, and D.H. McDermott Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease Blood 97 2001 1925 1928
30. D.H. McDermott, J.P.J. Halcox, W.H. Schenke, M.A. Waclawiw, M.N. Merrell, and N. Epstein Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis Circ Res 89 2001 401 407
31. F.M. Salzano N. Freire-Maia Problems in human biology. A study of Brazilian populations 1970 Wayne State University Press Detroit
32. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
33. D.K. Lahiri, and J.I. Nurnberger A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies Nucl Act Res 19 1991 5444
34. S. Schneider, D. Roessli, L. Excoffier, Arlequin ver. 2.000: a software for population genetics data analysis. 2000; Genetics and Biometry Laboratory. University of Geneva. Switzerland.
35. R.C. Lewontin On measures of gametic disequilibrium Genetics 120 1988 849 852
36. J.H. Abramson, and P.M. Gahlinger Computer programs for epidemiologists: PEPI. Version 4.0 2001 Sagebrush Press Salt Lake City
37. J.P. Casas, L.E. Bautista, S.E. Humphries, and A.D. Hingorani Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23,028 subjects Circulation 109 2004 1359 1365
38. A.S. Marroni, I.F. Metzger, D.C. Souza-Costa, S. Nagassaki, V.C. Sandrim, and R.X. Correa Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms Nitric Oxide 12 2005 177 182
39. Y. Miyamoto, Y. Saito, M. Nakayama, Y. Shimasaki, T. Yoshimura, and M. Yoshimura Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a - 786 T→C mutation associated with coronary spastic angina Hum Mol Genet 9 2000 2629 2637
40. G.P. Rossi, S. Taddei, A. Virdis, M. Cavallin, L. Ghiadoni, and S. Favilla The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients J Am Coll Cardiol 41 2003 938 945
41. J.E. Tanus-Santos, M. Desai, L.R. Deak, J.C. Pezzullo, D.R. Abernethy, and D.A. Flockhart Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol Pharmacogenetics 12 2002 407 413
42. M. Cataruzza, T.J. Guzik, W. Slodowski, A. Pelvan, J. Becker, and M. Halle Shear stress insensitivity of endothelial nitric oxide synthase expression as a genetic risk factor for coronary heart disease Circ Res 95 2004 841 847
43. D. Senthil, M. Raveendran, Y.H. Shen, B. Utama, D. Dudley, and J. Wang Genotype-dependent expression of endothelial nitric oxide synthase (eNOS) and its regulatory proteins in cultured endothelial cells DNA Cell Biol 24 2005 218 224
44. K.L. Chambliss, I.S. Yuhanna, C. Mineo, P. Liu, Z. German, and T.S. Sherman Estrogen receptor α and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae Circ Res 87 2000 e44 e52
45. T. Simoncini, G. Varone, L. Fornari, P. Mannella, M. Luisi, and F. Labrie Genomic and nongenomic mechanisms of nitric oxide synthesis induction in human endothelial cells by a fourth-generation selective estrogen receptor modulator Endocrinology 143 2002 2052 2061